A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
To learn if response-adapted, ultra-low dose radiation therapy can help to control MZL. This means participates first receive lower does of radiation therapy and then, based on how the disease responds, may receive higher doses after that.
Epistemonikos ID: ab1a0954272652ca1f0425fa114c6fe1333a29ce
First added on: May 15, 2024